“…It has been proposed that IGF2 could be a critical growth factor, a ecting the total number of tumors formed and their rate of growth (Fu et al, 1988;Yang et al, 1996;Schirmacher et al, 1992;Christofori et al, 1994). Christofori et al (1995) observed that endogenous IGF2 gene expression was activated in precancerous lesions and islet cell carcinomas of the pancreas in transgenic mice which express SV40 large T-antigen under regulation of the rat insulin promoter. To test the hypothesis that IGF2 had a functional role in the development of pancreatic tumors, SV40 T-antigen transgenic mice were crossed with transgenic mice containing an IGF2 gene knockout (De Chiara et al, 1990;Christofori et al, 1995).…”